Healthcare -
Biotechnology - NASDAQ - US
$ 9.91
14.2 %
$ 1.13 B
Market Cap
-2.77
P/E
DYN - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative DYN - Dyne Therapeutics, Inc.
62.5 M
LAST VALUE
48.84%
2 YEAR CAGR
86.27%
5 YEAR CAGR
10.21%
10 YEAR CAGR